---
$id: https://graph.org.ai/products/commodity/51121926
$type: Product
source: UNSPSC
code: "51121926"
title: "Simendan"
class: "51121900"
classTitle: "Drugs used for congestive heart failure"
family: "51120000"
familyTitle: "Antiarrythmics and antianginals and cardioplegics and drugs for heart failure"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Simendan

**UNSPSC Code**: 51121926
**Class**: [Drugs used for congestive heart failure](Drugs used for congestive heart failure.mdx)
**Family**: [Antiarrythmics and antianginals and cardioplegics and drugs for heart failure](../Antiarrythmics and antianginals and cardioplegics and drugs for heart failure.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cardiotonic agent with the molecular formula C14H12N6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 349552KRHK, chemically known as propanedinitrile, ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)- but generally known as simendan, which bears US NIH Compound Identifier 60867. European Medicines Agency schedules Simendan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10525MIG. The term SIMENDAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). Most nations schedule simendan under HS 29339990 and SITC 51577. As of Q4 2014, SIMENDAN remains the US FDA Preferred Term for this commodity. Simendan bears US NLM identifiers UMLS ID C0287806 and NCI Concept Code C87689. SMILES: O=C1NN=C(C(C1)C)C1CCC(N/N=C(/C#N)C#N)CC1.

